Champions Oncology (CSBR) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.94 --0%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $14 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
